Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Ushers Out Known DMAA, Closes Dietary Ingredient Door

22 Apr 2013

• By Malcolm Spicer

Related Content

Supreme Court Refuses Ephedra Case, Battle Against Risk-Benefit Continues

21 May 2007

FDA Using “All Available Tools” To Remove DMAA From Market

15 Apr 2013

DMAA Warnings Shed Light On FDA NDI Enforcement

07 May 2012

DMAA Supplements Banned In U.K., Hamstrung In U.S.

03 Sep 2012

Additional Topics

Mexico Business Strategies Advertising, Marketing & Sales Manufacturing Recalls Safety Post Market Regulation & Studies Regulation Legislation OTC Drugs Consumer

More from Latin America

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.